Annual Cash & Cash Equivalents
$8.56 M
+$7.24 M+552.13%
December 31, 2023
Summary
- As of February 8, 2025, INTS annual cash & cash equivalents is $8.56 million, with the most recent change of +$7.24 million (+552.13%) on December 31, 2023.
- During the last 3 years, INTS annual cash & cash equivalents has fallen by -$760.10 thousand (-8.16%).
- INTS annual cash & cash equivalents is now -8.16% below its all-time high of $9.32 million, reached on December 1, 2020.
Performance
INTS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$2.78 M
-$459.00 K-14.16%
September 30, 2024
Summary
- As of February 8, 2025, INTS quarterly cash and cash equivalents is $2.78 million, with the most recent change of -$459.00 thousand (-14.16%) on September 30, 2024.
- Over the past year, INTS quarterly cash and cash equivalents has stayed the same.
- INTS quarterly cash and cash equivalents is now -70.14% below its all-time high of $9.32 million, reached on December 1, 2020.
Performance
INTS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
INTS Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +552.1% | 0.0% |
3 y3 years | -8.2% | +351.3% |
5 y5 years | +123.5% | +351.3% |
INTS Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +552.1% | -67.5% | +1948.6% |
5 y | 5-year | -8.2% | +552.1% | -70.1% | +1948.6% |
alltime | all time | -8.2% | +552.1% | -70.1% | +1948.6% |
Intensity Therapeutics Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $2.78 M(-14.2%) |
Jun 2024 | - | $3.24 M(-56.5%) |
Mar 2024 | - | $7.46 M(-12.8%) |
Dec 2023 | $8.56 M(+552.1%) | $8.56 M(+27.8%) |
Sep 2023 | - | $6.69 M(+4829.2%) |
Jun 2023 | - | $135.80 K(-78.0%) |
Mar 2023 | - | $616.50 K(-53.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | $1.31 M(-71.1%) | $1.31 M(-23.8%) |
Jun 2022 | - | $1.72 M(-43.4%) |
Mar 2022 | - | $3.04 M(-33.0%) |
Dec 2021 | $4.54 M(-51.3%) | - |
Dec 2021 | - | $4.54 M(-38.7%) |
Sep 2021 | - | $7.41 M(-20.5%) |
Dec 2020 | $9.32 M(+143.3%) | $9.32 M |
Dec 2019 | $3.83 M | - |
FAQ
- What is Intensity Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Intensity Therapeutics?
- What is Intensity Therapeutics annual cash & cash equivalents year-on-year change?
- What is Intensity Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Intensity Therapeutics?
- What is Intensity Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Intensity Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of INTS is $8.56 M
What is the all time high annual cash & cash equivalents for Intensity Therapeutics?
Intensity Therapeutics all-time high annual cash & cash equivalents is $9.32 M
What is Intensity Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, INTS annual cash & cash equivalents has changed by +$7.24 M (+552.13%)
What is Intensity Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of INTS is $2.78 M
What is the all time high quarterly cash and cash equivalents for Intensity Therapeutics?
Intensity Therapeutics all-time high quarterly cash and cash equivalents is $9.32 M
What is Intensity Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, INTS quarterly cash and cash equivalents has changed by $0.00 (0.00%)